Publication | Closed Access

Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4

Tumor BiologyChemoprevention StrategyMedicineCancer BiologyPharmacotherapyAutocrine LoopAnti-cancer AgentNew Anticancer AgentPharmacologyCell BiologyMarine OriginCancer Research